Molecular and biochemical characterization of Mottled-dappled, an embryonic lethal Menkes disease mouse model

Marie Reine Haddad1, Keyur D Patel1, Patricia H Sullivan2

  • 1Section on Translational Neuroscience, Molecular Medicine Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

The Mottled-dappled mouse mutation involves an 8990 bp deletion in the Atp7a gene promoter, causing embryonic lethality and altered neurochemistry in carriers. This study details the molecular basis of this Menkes disease model.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuroscience

Background:

  • Menkes disease is a copper metabolism disorder caused by mutations in the ATP7A gene.
  • The Mottled-dappled (Mo-dp) mouse is a model for Menkes disease, exhibiting embryonic lethality and skeletal abnormalities.
  • The precise genetic cause of the Mo-dp allele was previously uncharacterized.

Purpose of the Study:

  • To molecularly characterize the Mo-dp mutation in the Atp7a gene.
  • To investigate the biochemical consequences of the Mo-dp mutation in heterozygous female mice.

Main Methods:

  • Comparative genomic hybridization using a custom microarray to identify the deletion.
  • Polymerase Chain Reaction (PCR) and DNA sequencing to fine-map deletion breakpoints.
  • Western blot analysis to assess Atp7a protein levels.
  • Neurochemical analysis of brain tissue from heterozygous and wild-type mice.

Main Results:

  • An 8990 bp deletion was identified in the 5' region of the Atp7a gene, including approximately 2 kb of the promoter region.
  • Western blot analysis revealed diminished Atp7a protein in heterozygous brains.
  • Heterozygous females exhibited lower brain copper levels and altered dopamine metabolism (increased DOPAC:DHPG and DA:NE ratios).
  • Affected embryos (Mo-dp mutants) showed severe skeletal malformations and died in utero.

Conclusions:

  • The Mo-dp mutation is a large deletion in the Atp7a promoter, explaining the observed phenotypes.
  • Heterozygous female carriers display biochemical alterations indicative of partial copper deficiency and impaired dopamine synthesis.
  • This study provides the first detailed molecular and biochemical characterization of the Mo-dp allele.

Related Concept Videos